Clinical Outcomes and Tolerability of a Retinoid-Based Serum Combined with Polypodium leucotomos-Containing Tinted Photoprotection in Melasma: An Exploratory Single-Arm Prospective Study
Life · 17.11.2026 · 16 (11) · 1947
DOI: 10.3390/life16111947 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 17.11.2026. Verfasst von Sirapob Seksunwiriya und 11 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine Siriraj Hospital, Mahidol University.
Abstract (Originalsprache)
Background
Melasma is a chronic relapsing pigmentary disorder in which ultraviolet and visible-light exposure may contribute to melanogenic signaling partly through oxidative stress.
Objective
To describe exploratory clinical and tolerability observations during use of an HPR/retinol-based serum with tinted sunscreen containing Polypodium leucotomos extract.
Methods
Thirty adults with melasma and Fitzpatrick skin types III–IV entered this single-arm prospective study. Serum was used nightly for 8 weeks and sunscreen daily for 12 weeks. Primary outcomes in the pre-enrollment protocol were Antera3D pigmentation and Mexameter melanin and erythema indices; physician-assessed severity and biophysical measures were secondary. Registration occurred after study completion.
Results
Twenty-seven participants completed follow-up. At month 3, reported mean Antera3D pigmentation decreased from 46.63 to 44.57, Mexameter melanin index from 262.90 to 224.60, and mMASI from 7.80 to 6.32, corresponding to descriptive reductions of 4.4%, 14.6%, and 19.0% in the respective group means. Reported p values were exploratory. Increased Cutometer R0 indicated greater deformation under suction and did not establish improved firmness or elasticity. Ten participants reported local irritation; no moderate or severe adverse events or adverse-event-related discontinuations were reported.
Conclusion
Modest within-cohort changes were observed. The uncontrolled concurrent-intervention design cannot establish efficacy, comparative effectiveness, synergy, or the contribution of either product or individual ingredient. These observations are hypothesis-generating; antioxidant-mediated efficacy cannot be inferred.
Förderung
- Faculty of Medicine Siriraj Hospital, Mahidol University
Zitieren
APA
Seksunwiriya, S., Wattanakul, S., Techapichetvanich, T., Maneeprasopchoke, P., Thongjaroensirikul, P., Nokdhes, Y., Buranaporn, P., Wannawittayapa, T., Tantrapongsathorn, W., Bhorntarakcharoen, W., Sittiwanaruk, S., & Wanitphakdeedecha, R. (2026). Clinical Outcomes and Tolerability of a Retinoid-Based Serum Combined with Polypodium leucotomos-Containing Tinted Photoprotection in Melasma: An Exploratory Single-Arm Prospective Study. Life, 16(11), 1947. https://doi.org/10.3390/life16111947
Vancouver
Seksunwiriya S, Wattanakul S, Techapichetvanich T, Maneeprasopchoke P, Thongjaroensirikul P, Nokdhes Y, et al. Clinical Outcomes and Tolerability of a Retinoid-Based Serum Combined with Polypodium leucotomos-Containing Tinted Photoprotection in Melasma: An Exploratory Single-Arm Prospective Study. Life. 2026;16(11):1947. doi:10.3390/life16111947
BibTeX
@article{Seksunwiriya2026,
author = {Seksunwiriya, Sirapob and Wattanakul, Soponvit and Techapichetvanich, Thanya and Maneeprasopchoke, Pitchaya and Thongjaroensirikul, Panwadee and Nokdhes, Ya-Nin and Buranaporn, Panyapat and Wannawittayapa, Teerapat and Tantrapongsathorn, Wetch and Bhorntarakcharoen, Woramate and Sittiwanaruk, Sariya and Wanitphakdeedecha, Rungsima},
title = {Clinical Outcomes and Tolerability of a Retinoid-Based Serum Combined with Polypodium leucotomos-Containing Tinted Photoprotection in Melasma: An Exploratory Single-Arm Prospective Study},
journal = {Life},
year = {2026},
volume = {16},
number = {11},
pages = {1947},
doi = {10.3390/life16111947}
}
EUVIMED